(Q45746813)

15 December 2017

title

Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene (English)

1 reference

15 December 2017

0 references

Colmenero P

1

1 reference

15 December 2017

Liljeström P

series ordinal

2

1 reference

15 December 2017

Jondal M

series ordinal

3

1 reference

15 December 2017

publication date

1 October 1999

1 reference

15 December 2017

published in

Gene Therapy

1 reference

15 December 2017

volume

6

1 reference

15 December 2017

issue

10

1 reference

15 December 2017

page(s)

1728-1733

1 reference

15 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301004

exact match

0 references

cites work

Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Induction of antigen-specific T cell anergy: An early event in the course of tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Tumor immunotherapy: the tumor cell as an antigen-presenting cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Considerations for the clinical development of cytokine gene-transduced tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Limited antitumor T cell response in melanoma patients vaccinated with interleukin-2 gene-transduced allogeneic melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

T cell defined tumor antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Mouse tumor rejection antigens P815A and P815B: two epitopes carried by a single peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Genes coding for tumor antigens recognized by cytolytic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T cells against a P1A-encoded tumor antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Generation of cytotoxic and humoral immune responses by nonreplicative recombinant Semliki Forest virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Enhancing immune responses using suicidal DNA vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

A new generation of animal cell expression vectors based on the Semliki Forest virus replicon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Outcome of immunization of cynomolgus monkeys with recombinant Semliki Forest virus encoding human immunodeficiency virus type 1 envelope protein and challenge with a high dose of SHIV-4 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. I. Rejection by syngeneic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen-loss variants rather than immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Death mechanisms in cultured cells infected by Semliki Forest virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Plasmid DNA expressing a secreted or a nonsecreted form of hepatitis C virus nucleocapsid: comparative studies of antibody and T-helper responses following genetic immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Tandem repeats of T helper epitopes enhance immunogenicity of fusion proteins by promoting processing and presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

T and B cell responses to chimeric proteins containing heterologous T helper epitopes inserted at different positions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

T cell priming versus T cell tolerance induced by synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Peptide vaccination can lead to enhanced tumor growth through specific T-cell tolerance induction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

The new vaccines: building viruses that elicit antitumor immunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Accidental human vaccination with vaccinia virus expressing nucleoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

A significantly improved Semliki Forest virus expression system based on translation enhancer segments from the viral capsid gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

Cross-presentation: a general mechanism for CTL immunity and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

CTL Response and Protection Against P815 Tumor Challenge in Mice Immunized with DNA Expressing the Tumor-Specific Antigen P815A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Identification and characterization of the tumor-specific P1A gene product

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Induction of a cytolytic T-cell response in mice with a recombinant adenovirus coding for tumor antigen P815A

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Individual differences in the orientation of the cytolytic T cell response against mouse tumor P815

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

CD8+ cell activation to a major mastocytoma rejection antigen, P815AB: requirement for tum- or helper peptides in priming for skin test reactivity to a P815AB-related peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Dendritic cells, interleukin 12, and CD4+ lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Influence of cellular location of expressed antigen on the efficacy of DNA vaccination: cytotoxic T lymphocyte and antibody responses are suboptimal when antigen is cytoplasmic after intramuscular DNA immunization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Immunization with a vaccinia virus recombinant expressing herpes simplex virus type 1 glycoprotein D: long-term protection and effect of revaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301004

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301004

1 reference

15 December 2017

Dimensions Publication ID

0 references

1 reference

15 December 2017